Skip to content
Radio Logo
PodcastsHealth & WellnessConversations in Drug Development

Conversations in Drug Development

Boyds
Latest episode

29 episodes

  • Conversations in Drug Development

    EU Device Reform: What MDR & IVDR Changes Mean for Innovators

    17/11/2026 | 28 mins.
    This episode unpacks the European Commission’s December 2025 proposal to amend the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR). Eric Hardter and Eamonn McGowran from Boyds review key reforms - simplification and proportionality, reduced administrative burden, support for breakthrough and orphan devices, better EU coordination, digitalization, and increased EMA involvement - and explain what these changes could mean for manufacturers, small developers, and patient access.
  • Conversations in Drug Development

    Ada Lovelace Day: Breaking Barriers, Shaping Futures

    13/10/2026 | 17 mins.
    To celebrate Ada Lovelace Day, women from Boyds share their career journeys, the challenges they’ve overcome and their advice for the next generation of women in science.
  • Conversations in Drug Development

    EU Pharma Reform 2026: What Every Developer Needs to Know

    07/10/2026 | 37 mins.
    In this episode, Katherine Bowen and Shalini Gupta discuss the EU pharmaceutical legislation reform — a comprehensive update to regulations and directives that will affect drug approval, orphan and paediatric rules, exclusivity incentives, EMA structure and timelines, supply obligations, environmental risk assessments, and transparency requirements.

    Hosts outline the timeline, key practical impacts for sponsors, and recommended next steps: begin preparing now, align regulatory, market‑access and supply strategies, and monitor EMA guidance during the transition period.
  • Conversations in Drug Development

    Live Biotherapeutics: Navigating the Next Frontier in Drug Development

    22/06/2026 | 32 mins.
    In this episode, Boyds' experts explore the emerging field of live biotherapeutic products (LBPs), explaining what they are, how they differ from everyday probiotics, and their roots in microbiome-based therapies, including fecal microbiota transplantation (FMT).

    Katherine and Celine discuss the evolving regulatory landscape, comparing the FDA's guidance and recent approvals with the more cautious approach taken by the EMA and national authorities across Europe. They also examine the scientific, manufacturing, and clinical development challenges facing LBP developers, including product consistency, mechanism of action, safety considerations, and clinical trial design.
  • Conversations in Drug Development

    UK Clinical Trial Regulation: What Sponsors Need to Know About UK CTR 2025

    08/04/2026 | 25 mins.
    In this episode, experts at Boyds, Chris Moore and Shalini Gupta break down the UK Clinical Trial Regulation (UK CTR), exploring why the reform was introduced and highlighting the practical changes sponsors need to know - including new terminology, updated timelines, notifiable trials, transparency obligations, safety reporting, and labelling updates.

    Listeners will gain insight into how these changes will affect trial set-up and operations, what to prepare for ahead of the 28 April 2026 implementation date, and where opportunities exist for faster, more predictable approvals.
More Health & Wellness podcasts
About Conversations in Drug Development
Welcome to Conversations in Drug Development, brought to you by the team at Boyds for our fellow community of scientists and clinicians working in the wonderful world of cell and gene therapy and drug development. This podcast series features candid conversations from the expert team at Boyds, who are at the forefront of cutting-edge science and drug development in the pharmaceutical and biotechnology sector.
Podcast website

Listen to Conversations in Drug Development, A New Day with Gerry Hussey and many other podcasts from around the world with the radio.net app

Get the free radio.net app

  • Stations and podcasts to bookmark
  • Stream via Wi-Fi or Bluetooth
  • Supports Carplay & Android Auto
  • Many other app features
Conversations in Drug Development: Podcasts in Family